Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Abroad (travel likely)RecruitingPHASE2
Conditions
Pheochromocytoma · Paraganglioma · Neuroendocrine Tumors · Neuroendocrine Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Study leads
Frank I Lin, M.D.
Principal Investigator
National Cancer Institute (NCI)